Astellas Pharma Value Stock - Dividend - Research Selection
Market price: 1.760,50 JPY
Astellas Pharma Inc Fundamental data and company key figures of the share
|Annual reports in JPY|
|Net operating cash flow||307.880.000.000|
|Free cash flow||276.495.990.784|
|Liabilities & Shareholders equity||2.273.630.000.000|
|Diluted shares outstanding||1.860.000.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||31.570.255.872,00 USD|
|Raw Data Source||IFRS in Millionen JPY|
|Stock Split||2014-03-27,5.0000/1.0000; 2014-03-26,5.0000/1.0000|
Description of the company
Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.